ELK elk range mining ltd

5.26%

18.0¢

Grieve production, page-3

First 3 Last

Share
Profile

Follow
danpech

837 Posts.

34

11/04/18

12:10

Post #: 32374246
Share

Originally posted by ExpatSingapore ↑

I remain bullish on Elk and am a fan of what Brad Lingo has done to position Elk for scale and profitability. Good to hear that Brad believes Grieve production to be just a few days away from now.

That said, the OGIS presentation posted earlier today appears to be a sloppy and careless rehash. One glaring example: Slide 19 - last bullet on the page - states that Grieve production "is expected late Q1 2018".

More interesting is Slide #4 which includes the following assertions:

- Market cap of US$ 165 million
- PV of US$ 410 million . . . suggesting a roughly 2.5x uplift in current share-price
- Long term debt of US$ 175 million
- Debt to EBITDA ratio of 3.0

That last bullet appears to be - again carelessly - over-optimistic, given forecast 2018 EBITDA of US$50 million. Because the debt is presumably both real and now/today. While the forecast EBITDA depends on clean execution over another 2-plus months of this fiscal year.

Possibly I just missed it - or perhaps it wasn't included in the presention - but can anyone comment on what Elk's forecast 2018 debt-servicing costs are on the $175 million of debt contrasted with refinanced debt-servicing costs, once Grieve production is proven rather than promised ?

I'm mindful that EBITDA means Earnings before INTEREST, etc. So I am trying to understand what the bottom-line for net profit looks like for both 2018 and 2019 ?

I continue to believe that Elk's share price will cross 20 cents per share by the time full-year results are reported for FY2018. But probably my earlier call of "above 25 cents by mid-August" was over-optimistic. I have already guessed wrongly - badly - by predicting that Elk's share-price would cross 20 cents per share by mid-February.

Sign me still bullish but (somewhat) chastened. Not a seller below 25 cents based on current prospects though.

Expand

Hi Expat

Elk have stated that they are expecting an annual cashflow bebefit of US 20-25 million on refinancing the debt through a combination of lower interest rate and less onerous amortisation .

cheers

Dan

ELK Price at posting: 8.9¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

TGN

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

D3E

D3 Energy detects gas in South African helium hunt well

IMR

Imricor Med and Philips launch commercial iMR lab solution

MEM

Memphasys receives early Thai FDA Felix approval

CVL

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

4DX

4DMedical posts FY26 revenue growth as commercial deployment ramps up

NVA

Nova Minerals achieves key milestone on path to Alaskan antimony production

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

SEN

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

AS2

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

First 3 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 18.0¢		Change -0.010(5.26%)		Mkt cap ! $23.95M

Open	High	Low	Volume
18.5¢	19.0¢	18.0¢	267.4K

Buyers (Bids)

Vol.	Price($)
6152	18.0¢

Sellers (Offers)

Price($)	Vol.
18.5¢	8516

Last trade - 15.54pm 28/08/2026 (20 minute delay)

ELK (ASX) Chart

Grieve production, page-3

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

D3 Energy detects gas in South African helium hunt well

Imricor Med and Philips launch commercial iMR lab solution

Memphasys receives early Thai FDA Felix approval

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

4DMedical posts FY26 revenue growth as commercial deployment ramps up

Nova Minerals achieves key milestone on path to Alaskan antimony production

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Grieve production, page-3

Top Stories

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

D3 Energy detects gas in South African helium hunt well

Imricor Med and Philips launch commercial iMR lab solution

Memphasys receives early Thai FDA Felix approval

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

4DMedical posts FY26 revenue growth as commercial deployment ramps up

Nova Minerals achieves key milestone on path to Alaskan antimony production

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News